针对原蛋白的抗血栓的智能设计
1Department of Biochemical Engineering and Frontiers Science Center for Synthetic Biology and Key Laboratory of Systems Bioengineering (MOE), School of Chemical Engineering and Technology, Tianjin University, Tianjin 300350, People's Republic of China.
Langmuir : the ACS journal of surfaces and colloids
|April 26, 2024
概括
研究人员开发了一种神经网络模型,即蛋白质匹配器的智能设计 (IDProMat),用于设计抗血栓. 这种由人工智能驱动的方法成功地产生了与原结合的,抑制了血栓形成.
科学领域:
- 生物技术是生物技术.
- 计算生物学 计算生物学
- 生物化学 生化学
背景情况:
- 血栓的形成是由血液成分与原蛋白的结合启动的.
- 针对这种原结合相互作用是开发抗血栓治疗的关键策略.
研究的目的:
- 开发一种新的计算模型,用于设计可以与原蛋白结合的.
- 使用开发的模型创建一个有效的抗血栓性.
主要方法:
- 基于seq2seq原则开发蛋白质匹配器智能设计 (IDProMat) 神经网络模型.
- 培训 IDProMat 关于序数据和原相互作用模式的培训.
- IDProMat的应用用于设计原结合.
- 用分子对接,分子动力学 (MD) 模拟和实验分析验证设计 (LRWNSYY).
主要成果:
- IDProMat证明了对残留物相互作用模式的显著学习,seq2seq损失减少了99.3%,MLP损失减少了58.3%.
- 该模型成功设计了一种高效的抗血栓性,LRWNSYY.
- LRWNSYY显示了验证的结合原和抑制血小板粘附.
结论:
- IDProMat模型对于设计具有抗血栓潜力的原向质有效.
- 设计的酸LRWNSYY代表了进一步开发抗血栓治疗的有希望的候选人.
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
687
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
687
Clot Retraction and Fibrinolysis
5.7K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
5.7K
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
522
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
522
Intracellular Signaling Affects Focal Adhesions
2.7K
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...
2.7K


